111 (YI) Insider Sun Jian David Buys 18,366 Shares
The purchase comes as the Chinese digital healthcare platform navigates a challenging market and works toward profitability.
Reviewed by automated data checks against the source filing. How we make and check alerts
Sun Jian David bought 18,366 shares of 111, Inc. ($YI) on September 12, 2018. The trade was reported to the SEC in a Form 4 filing.
YI
111, Inc.
Key Points
- Insider Sun Jian David acquired 18,366 shares of 111, Inc. on September 12, 2018.
- The company operates an integrated online and offline healthcare platform in China and reports a market capitalization of $32.1 million.
- While 111, Inc. is currently unprofitable with an EPS of -$1.79, analysts project a forward P/E ratio of 26.04.
Get $YI trade alerts by text
We text you when insiders, Congress or big funds trade $YI. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated 111, Inc. alert may contain errors. Disclosures
Sun Jian David Adds to Holdings
Insider Sun Jian David acquired 18,366 shares of 111, Inc. (NASDAQ:YI) on September 12, 2018. This transaction represents a vote of confidence in the Chinese digital healthcare company's long-term business strategy. The trade was executed as an direct purchase, though specific pricing and dollar value details for this transaction were not publicly reported in the filing disclosures.
This transaction is part of a broader pattern of insider buying at the firm. Over the years, other key insiders have also stepped up their ownership. For instance, Chen Yang Luke acquired 126,295 shares on September 8, 2023. More recently, both Sun Jian David and Chen Yang Luke made substantial purchases in May 2026. On May 11, 2026, Sun Jian David bought 378,737 shares and Chen Yang Luke acquired 54,759 shares. The following day, on May 12, 2026, both insiders increased their stakes further by purchasing 413,168 shares each.
111, Inc. Stock Performance
On Tuesday, shares of 111, Inc. closed at $4.57. The stock has experienced considerable volatility, trading within a 52-week range of $2.48 to $11.17. Investors are closely watching the stock as it trades below its 200-day moving average of $5.09, though it remains above its 50-day moving average of $3.64. The company currently has a market capitalization of $32.1 million.
Recent Earnings and Financial Health
In its most recent financial reports, 111, Inc. posted annual revenue of $10.48 billion, representing a revenue decline of 28.3%. The company is not currently profitable, posting an EPS of -$1.79 and a negative return on equity of 27.53%. Its net margin stands at -1.01%. Despite the current losses, forward-looking expectations are more optimistic, with a forward P/E ratio of 26.04. The company's next earnings report is scheduled for March 19, 2026.
About the Company
111, Inc. operates an integrated online and offline platform in the healthcare market of the People's Republic of China. The company serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. It distributes pharmaceutical and health products through its wholesale and retail online pharmacy networks, while also offering cloud-based inventory management, smart procurement, and online consultation services.
What to Watch
Investors will want to monitor whether the steady stream of insider purchases translates into improved financial performance in the coming quarters. The next major milestone for the company will be its upcoming earnings release on March 19, 2026, which should provide clearer insights into its cost management and revenue stabilization efforts.
Related Filing Alerts
Source: Sun Jian David's Form 4 filing on $YI (Sep 12, 2018). Find the original filing: YI Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts